Cargando…
The cocrystal 10-(2-methyl-4-phenyl-1H-inden-6-yl)-10H-phenothiazine–10-(2-methyl-7-phenyl-1H-inden-5-yl)-10H-phenothiazine (0.54/0.46)
The title compound, 0.535C(28)H(21)NS.0.465C(28)H(21)NS, was synthesized by palladium-catalysed amination. The structure is composed of two isomeric molecules, viz. 10-(2-methyl-4-phenyl-1H-inden-6-yl)-10H-phenothiazine, and 10-(2-methyl-7-phenyl-1H-inden-5-yl)-10H-phenothiazine, in the refined r...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2959856/ https://www.ncbi.nlm.nih.gov/pubmed/21581293 http://dx.doi.org/10.1107/S1600536808036210 |
Sumario: | The title compound, 0.535C(28)H(21)NS.0.465C(28)H(21)NS, was synthesized by palladium-catalysed amination. The structure is composed of two isomeric molecules, viz. 10-(2-methyl-4-phenyl-1H-inden-6-yl)-10H-phenothiazine, and 10-(2-methyl-7-phenyl-1H-inden-5-yl)-10H-phenothiazine, in the refined ratio 0.535 (12):0.465 (12). The isomers differ by the localization of the double bond in the cyclopentadiene ring. There are two sites in the structure that are occupied by the isomers. The respective isomers are occupationally disordered in each site, the refined proportions being 0.640 (6):0.360 (6) and 0.43 (1):0.57 (1). Moreover, each isomeric molecule is chiral; due to the crystallographic centres of symmetry, the molecules are also present in enantiomeric pairs. The crystal structure is stabilized by weak π–π [C⋯C = 3.389 (2) Å] interactions. |
---|